Cross-linking of antioxidant-containing polymers

Patent metadata

Field	Value
Publication number	US-2016296661-A1
Application number	US-201615184228-A
Country	US
Kind code	A1
Filing date	Jun 16, 2016
Priority date	Mar 2, 2007
Publication date	Oct 13, 2016
Grant date	—

Abstract

The present invention relates to methods for making cross-linked, oxidatively stable, and highly crystalline polymeric materials. The invention also provides methods of treating irradiation-cross-linked antioxidant-containing polymers and materials used therewith.

First claim

What is claimed is:

1 - 33 . (canceled)

34 . A medical device comprising a highly cross-linked, oxidatively stable, and highly crystalline polymeric material, wherein the highly cross-linked, oxidatively stable, and highly crystalline polymeric material is made by a process comprising the steps of:
a) blending antioxidant with UHMWPE resin, powder, or flake in the absence of a supercritical fluid, thereby providing a polymeric blend, wherein the blend is mixed with virgin UHMWPE resin, powder, or flake, thereby forming a composition having antioxidant rich and poor regions; b) consolidating the blend from step (a) to provide a consolidated polymeric material having antioxidant rich and poor regions; c) irradiating the consolidated polymeric material from step (b) at a temperature that is above the room temperature and below the melting point of the polymeric material to provide an irradiated and consolidated polymeric material having antioxidant rich and poor regions; and d) annealing the irradiated and consolidated polymeric material in air or under an inert environment at a temperature below the melting temperature of the polymeric material, thereby forming a highly cross-linked, oxidatively stable, and highly crystalline polymeric material.

35 . A medical device comprising a highly cross-linked, oxidatively stable, and highly crystalline polymeric material, wherein the highly cross-linked, oxidatively stable, and highly crystalline polymeric material is made by a process comprising the steps of:
a) blending antioxidant with UHMWPE resin, powder, or flake in the absence of a supercritical fluid, thereby providing a polymeric blend, wherein the blend is mixed with virgin UHMWPE resin, powder, or flake, thereby forming a composition having antioxidant rich and poor regions; b) consolidating the blend from step (a) to provide a consolidated polymeric material having antioxidant rich and poor regions; c) irradiating the consolidated polymeric material from step (b) at a temperature that is above the room temperature and below the melting point of the polymeric material to provide an irradiated and consolidated polymeric material having antioxidant rich and poor regions; and d) quenching residual free radicals by annealing the irradiated and consolidated polymeric material in air or under an inert environment at a temperature below the melting temperature of the polymeric material, thereby forming a highly cross-linked, oxidatively stable, and highly crystalline polymeric material.

36 . The medical device of claim 34 , wherein the polymeric material is machined subsequently after consolidation, irradiation, heating and/or annealing or a quenching step.

37 . The medical device of claim 34 is soaked in a solution, of about 50% by weight, of the antioxidant in ethanol.

38 . The medical device of claim 34 , is contacted, diffused, or homogenized with an antioxidant in a supercritical fluid.

39 . The medical device of claim 38 , wherein the supercritical fluid is CO 2 .

40 . The medical device of claim 34 is selected from the group consisting of acetabular liner, shoulder glenoid, patellar component, finger joint component, ankle joint component, elbow joint component, wrist joint component, toe joint component, bipolar hip replacements, tibial knee insert, tibial knee inserts with reinforcing metallic and polymeric posts, intervertebral discs, interpositional devices for any joint, sutures, tendons, heart valves, stents, and vascular grafts.

41 . The medical device of claim 34 is a non-permanent medical device, wherein the non-permanent medical device is selected from the group consisting of a catheter, a balloon catheter, a tubing, an intravenous tubing, and a suture.

42 . The medical device of claim 34 is packaged and sterilized by ionizing radiation or gas sterilization, thereby forming a sterile, highly cross-linked, oxidatively stable, and highly crystalline medical device.

43 . The medical device of claim 34 , wherein the crystallinity of the polymeric material is greater than about 51%.

44 . The medical device of claim 34 , wherein one or more types of resin, flakes, or powder are blended with different concentrations of an antioxidant.

45 . The medical device of claim 34 , wherein the highly cross-linked, oxidatively stable, and highly crystalline polymeric material is further doped with an antioxidant by diffusion at a temperature below the melting point of the polymeric material.

46 . The medical device of claim 34 , wherein the antioxidant is vitamin E.

47 . The medical device of claim 34 , wherein a portion or all of the highly cross-linked, oxidatively stable, and highly crystalline polymeric material is further thermally annealed below the melting point of the polymeric material.

48 . The medical device of claim 34 , wherein the antioxidant blended polymeric material, the consolidated polymeric material, or the highly cross-linked, oxidatively stable, and highly crystalline polymeric material is compression molded to another piece or a medical implant, thereby forming an interface or an interlocked hybrid material.

49 . The medical device of claim 34 , wherein the polymeric material is a polyolefin, a polypropylene, a polyamide, a polyether ketone, a hydrogel or a mixture thereof.

50 . The medical device of claim 49 , wherein the polyolefin is selected from a group consisting of a low-density polyethylene, high-density polyethylene, linear low-density polyethylene, ultra-high molecular weight polyethylene (UHMWPE), or a mixture thereof.

51 . The medical device of claim 34 , wherein the radiation dose is between about 25 and about 1000 kGy.

52 . The medical device of claim 34 , wherein the radiation dose is about 65 kGy.

53 . The medical device of claim 34 , wherein the radiation dose is about 75 kGy.

54 . The medical device of claim 34 , wherein the consolidated polymeric material is irradiated at a temperature that is between about 75° C. and about 135° C.

Assignees

• Muratoglu Orhun K
• Spiegelberg Stephen H
• Massachusetts Gen Hospital
• Cambridge Polymer Group Inc

Inventors

• Muratoglu Orhun K
• Spiegelberg Stephen H

Classifications

• C08K2201/012

  Additives improving oxygen scavenging properties · CPC title

• C08K5/1545

  Six-membered rings · CPC title

• C08J3/247

  Heating methods · CPC title

• A61L2430/02

  for reconstruction of bones; weight-bearing implants · CPC title

• A61L29/143

  Stabilizers · CPC title